Esmolol (trade name Brevibloc) is a cardioselective beta1 receptor blocker with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane stabilising activity at therapeutic dosages.
2 edits since May 19, 2008. Last edited Jul 27, 2008 by Arcadian (275).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Esmolol. See this site's terms for details.